Dr. Weinstock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA 02215Phone+1 617-667-9920Fax+1 617-667-9922
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
Brigham and Women's HospitalResidency, Internal Medicine, 2010 - 2013
Columbia University Vagelos College of Physicians and SurgeonsClass of 2010
Certifications & Licensure
MA State Medical License 2012 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) in a Treatment-Naive CLL Population Enriched for High-Risk Disease.Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva
Journal of Clinical Oncology. 2024-12-07 - Transdifferentiation of diffuse large B-cell lymphoma to a poorly differentiated neoplasm following CAR T-cell therapy.Nandan Padmanabha, Matthew J Weinstock, Sean Xu, Marcos Lepe, Leslie A Garrett
Journal of Hematopathology. 2024-09-01 - High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality.Zachary M Avigan, Ajoy L Dias, Laura E Dodge, Jon E Arnason, Robin M Joyce
Transfusion. 2024-06-01
Abstracts/Posters
- Transcriptome Sequencing Demonstrates Unique Signature Associated with Durable Clinical Response to DC/AML Fusion VaccineMatthew Weinstock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Development of Novel Second Generation DC/Tumor Fusion Vaccine in LymphomaMatthew Weinstock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- T Cells Educated By DC/AML Fusions in the Context of 4-1BB Costimulation As a Potent Strategy for Adoptive Cellular TherapyMatthew Weinstock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Triplet Therapy Shows Promise in Phase 2 Study in Chronic Lymphocytic LeukemiaSeptember 15th, 2021- The Check up: Brandon Fryar of Presbyterian Health PlanMay 17th, 2021
- Webinar: Avoiding Interoperability PenaltiesMarch 23rd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
